“The Mitigating Role of Transresveratrol Against Doxorubicin-Induced Cardiotoxicity in Breast Cancer Patients via Modulating Mitochondrial Gene Expression: A Randomized Controlled Trial” (2024) Journal of Carcinogenesis, 23(1), pp. 751–770. doi:10.64149/J.Carcinog.23.1.751-770.